You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

relapsing chronic myelogenous leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)

Not yet recruiting
  • Chronic Myelogenous Leukemia
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Oct 12, 2023

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Chronic Myeloid Leukemia, Chronic Phase Trial in Monterrey (Dasatinib Pill, Ketoconazole Pill)

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Dasatinib Pill
  • Ketoconazole Pill
  • Monterrey, Nuevo Leon, Mexico
    Hospital Universitario Dr. José Eleuterio González
Nov 25, 2022

Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

Active, not recruiting
  • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 2, 2022

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Jun 24, 2022

Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

Not yet recruiting
  • Chronic Myelogenous Leukemia - Chronic Phase
  • APN and medical management
  • +3 more
  • Avignon, Provence-Alpes-Côte d'Azur, France
    Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
Oct 13, 2023

Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -

Recruiting
  • Chronic Myeloid Leukemia in Myeloid Blast Crisis
  • +3 more
  • based decitabine and olverembatinib（HQP1351)chemotherapy
  • Guanzhou, China
    Department of Hematology, Nanfang Hospital, Southern Medical Uni
Dec 6, 2022

Asciminib RMP Study

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Asciminib
  • (no location specified)
Jul 5, 2023

Chronic Myelogenous Leukemia Trial in Beijing (TGRX-678)

Recruiting
  • Chronic Myelogenous Leukemia
  • Beijing, Beijing, China
    Peking University People's Hospital
Jun 27, 2022

Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Trial (Asciminib, Imatinib)

Not yet recruiting
  • Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
  • (no location specified)
Jun 7, 2022

Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

Completed
  • Chronic Myeloid Leukemia
    • East Hanover, New Jersey
      Novartis
    Nov 20, 2023

    Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete

    Completed
    Has Results
    • Myeloproliferative Disorders
    • +4 more
    • T-cell replete PBPC allograft
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Oct 12, 2022

    Chronic Myeloid Leukemia Trial in France (biological samples)

    Completed
    • Chronic Myeloid Leukemia
    • biological samples
    • Belfort, France
    • +3 more
    May 31, 2022

    Ponatinib in CML Patients in Chronic Phase

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Therapeutic drug monitoring
    • Molecular Response
    • Cagliari, Italy
    • +4 more
    Nov 3, 2023

    Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any

    Active, not recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
      • Jena, Germany
        University Hospital Jena
      Jan 17, 2023

      Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

      Recruiting
      • Chronic Phase Chronic Myelogenous Leukemia
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 11, 2022

      Chronic Myelogenous Leukemia - Chronic Phase Trial (asciminib)

      Recruiting
      • Chronic Myelogenous Leukemia - Chronic Phase
      • Birmingham, Alabama
      • +25 more
      Jan 10, 2023

      Leukemia, Chronic Myelogenous Trial in China (asciminib, best available treatment)

      Recruiting
      • Leukemia, Chronic Myelogenous
      • Chongqing City, Chongqing, China
      • +23 more
      Jan 18, 2023

      CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

      Recruiting
      • CML
      • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
      • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
        FUNDALEU
      Jun 29, 2023

      Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

      Not yet recruiting
      • Acute Lymphoblastic Leukemia
      • +6 more
      • Miltenyi CliniMACS Prodigy ® system
      • (no location specified)
      Mar 23, 2023

      Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))

      Not yet recruiting
      • Leukemia
      • +12 more
      • Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
      • (no location specified)
      Mar 20, 2023

      Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

      Recruiting
      • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +2 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 15, 2022

      Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

      Recruiting
      • Acute Biphenotypic Leukemia
      • +13 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 19, 2023

      Chronic Leukemia Trial in France (Additional biological samples)

      Active, not recruiting
      • Chronic Leukemia
      • Additional biological samples
      • Besançon, France
      • +3 more
      May 31, 2022